Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,515 | -11,901 | -16,058 | -26,648 | -6,617 |
| Depreciation Amortization | 9,712 | 37 | 17,631 | 106 | 46 |
| Income taxes - deferred | -446 | 97 | -1,612 | 20 | 165 |
| Accounts receivable | N/A | N/A | N/A | N/A | 95 |
| Accounts payable and accrued liabilities | -4,108 | 2,165 | 6,207 | -1,311 | -62 |
| Other Working Capital | 63 | 3,352 | -328 | 5,570 | 445 |
| Other Operating Activity | 1,942 | -6,495 | -22,657 | 7,377 | -1,323 |
| Operating Cash Flow | $-17,352 | $-12,745 | $-16,817 | $-14,886 | $-7,251 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -298 | N/A | -18 | N/A | -3 |
| Net Acquisitions | N/A | N/A | 809 | 1,005 | N/A |
| Investing Cash Flow | $-298 | $N/A | $791 | $1,005 | $-3 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,340 | 1,050 | 1,000 | 3,998 | 3,002 |
| Debt Repayment | -1,340 | -3,699 | N/A | -2,945 | -533 |
| Common Stock Issued | 37,354 | 16,895 | N/A | 34,890 | 3,703 |
| Other Financing Activity | -562 | -3,251 | -2,311 | -2,125 | -139 |
| Financing Cash Flow | $36,792 | $10,995 | $-1,311 | $33,818 | $6,033 |
| Exchange Rate Effect | 225 | -113 | -189 | -680 | -5 |
| Beginning Cash Position | 166 | 2,029 | 19,555 | 298 | 1,524 |
| End Cash Position | 19,533 | 166 | 2,029 | 19,555 | 298 |
| Net Cash Flow | $19,367 | $-1,863 | $-17,526 | $19,257 | $-1,226 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,352 | -12,745 | -16,817 | -14,886 | -7,251 |
| Capital Expenditure | -298 | N/A | -18 | 0 | -3 |
| Free Cash Flow | -17,650 | -12,745 | -16,835 | -14,886 | -7,254 |